The new patent entitled ‘Polyoxazoline and compositions comprising the same,’ covers the synthesis and composition of polyoxazolines for the delivery of different drug molecules.
Serina chief scientific officer and co-founder Michael Bentley said this patent award validates their invention and design of a novel drug delivery platform and allows Serina the opportunity to advance some of its proprietary ideas towards full development and eventually commercialization.
Serina is a pharmaceutical company that develops novel polymer therapeutics based on its proprietary polyoxazoline (POZ) technology platforms.